{"id":"CHEMBL10372","canonicalSmiles":"O=C(O)Cc1nn(Cc2nc3cc(C(F)(F)F)ccc3s2)c(=O)c2ccccc12","inchiKey":"BCSVCWVQNOXFGL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOPOLRESTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-73,850","Zopolrestat"],"crossReferences":{"drugbank":["DB08772"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1076241","canonicalSmiles":"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"OZDXXJABMOYNGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1076241","maximumClinicalTrialPhase":0,"parentId":"CHEMBL554","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1076930","canonicalSmiles":"CO[C@@H]1[C@H](OP(=O)(OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)C[C@@H]2O)SCOC(=O)OC(C)C)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O","inchiKey":"CJCYTUJOSMYXLE-JDLSZIHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INARIGIVIR SOPROXIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inarigivir soproxil","SB 9200","SB-44","SB-9200","Sb 9200"],"crossReferences":{"drugbank":["DB15063"]},"childChemblIds":["CHEMBL3526317"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1086997","canonicalSmiles":"CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO","inchiKey":"UQRORFVVSGFNRO-XFWSIPNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUCERASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-434964","Lucerastat","N-N-Butyl Deoxygalactonojirimycin"],"crossReferences":{"drugbank":["DB14872"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL109005","canonicalSmiles":"CC(=O)Nc1c(N)cc(C(=O)O)cc1O","inchiKey":"CALDTVBHJMBRTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109005","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08571"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL11608","canonicalSmiles":"NCCc1ccc(O)cc1","inchiKey":"DZGWFCGJZKJUFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYRAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 4215","NSC-249188","Ractopamine hydrochloride suspension impurity, tyramine-","Tyramine"],"crossReferences":{"PubChem":["104171251","11111872","144203833","170466815","858070","90341354"],"Wikipedia":["Tyramine"],"drugbank":["DB08841"],"chEBI":["15760"]},"childChemblIds":["CHEMBL1255790"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL117822","canonicalSmiles":"C=C","inchiKey":"VGGSQFUCUMXWEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethylene"],"crossReferences":{"Wikipedia":["Ethylene"],"chEBI":["18153"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL119296","canonicalSmiles":"NCCCCCN","inchiKey":"VHRGRCVQAFMJIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Pentane-1,5-Diamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pentane-1,5-Diamine"],"crossReferences":{"PubChem":["29218043"],"Wikipedia":["Cadaverine"],"drugbank":["DB03854"],"chEBI":["18127"]},"childChemblIds":["CHEMBL3351096"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200341","canonicalSmiles":"CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21.Cl","inchiKey":"NXNSCUZKMVYAJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDECAINIDE HYDROCHLORIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201242","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decabid"],"synonyms":["Indecainide hydrochloride","LY-135837","Ricainide"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1200356","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(=O)O","inchiKey":"HGBLNBBNRORJKI-WCABBAIRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLACILLIN","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calthor","Cyclacillin","Cyclapen","Cyclapen-w","Vasticillin"],"synonyms":["Ciclacillin","Cyclacillin","WY-4508"],"crossReferences":{"PubChem":["11112536","144204085","396250"],"Wikipedia":["Ciclacillin"],"drugbank":["DB01000"],"chEBI":["31444"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL1200473","canonicalSmiles":"CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1.Cl","inchiKey":"RHKZVMUBMXGOLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPENTOLATE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201338","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ak-pentolate","Akpentolate","Alnide","Cyclogyl","Cyclopentolate hydrochloride","Mydrilate","Pentolair"],"synonyms":["Cyclopentolate hydrochloride"],"crossReferences":{"DailyMed":["cyclopentolate%20hydrochloride"],"PubChem":["170464720","26747954","56320713","855558"],"Wikipedia":["Cyclopentolate"],"chEBI":["4025"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1200903","canonicalSmiles":"C=CCC1(C(C)CCC)C(=O)[N-]C(=O)NC1=O.[Na+]","inchiKey":"AXXJTNXVUHVOJW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SECOBARBITAL SODIUM","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL447","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Secobarbital sodium","Seconal sodium","Seconesin","Tuinal"],"synonyms":["Quinalbarbitone sodium","Secobarbital sodium"],"crossReferences":{"DailyMed":["secobarbital%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950. It was withdrawn in France and  Norway initially in 1980 due to Misuse."}
{"id":"CHEMBL1201482","drugType":"Enzyme","blackBoxWarning":false,"name":"PROTEASE (PANCRELIPASE)","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Protease","Protease (pancrelipase)"],"crossReferences":{"DailyMed":["protease%20(pancrelipase)"]},"count":3,"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 investigational indications."}
{"id":"CHEMBL1201626","drugType":"Unknown","blackBoxWarning":false,"name":"CHYMOPAPAIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chymodiactin","Discase"],"synonyms":["BAX 1526","Chymopapain"],"crossReferences":{"DrugCentral":["5131"],"Wikipedia":["Chymopapain"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201758","canonicalSmiles":"O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1","inchiKey":"YWGDOWXRIALTES-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPOTASTINE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bepreve"],"synonyms":["Bepotastine"],"crossReferences":{"DailyMed":["bepotastine%20besilate"],"Wikipedia":["Bepotastine"],"chEBI":["71204"]},"childChemblIds":["CHEMBL1201759"],"count":5,"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0002406","EFO_0007141","EFO_1001417","EFO_0003956","EFO_0003785"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 5 investigational indications."}
{"id":"CHEMBL1201777","canonicalSmiles":"CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C.Cl","inchiKey":"ZELFLGGRLLOERW-YECZQDJWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TAPENTADOL HYDROCHLORIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201776","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nucynta","Nucynta er","Palexia"],"synonyms":["BN-200 HYDROCHLORIDE","CG-5503 HYDROCHLORIDE","CG5503 HYDROCHLORIDE","Tapentadol hydrochloride"],"crossReferences":{"DailyMed":["tapentadol%20hydrochloride"]},"count":3,"approvedIndications":["EFO_0005762","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_1000786","EFO_0004616","HP_0003419","EFO_0003843"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for pain and neuropathic pain and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1207907","canonicalSmiles":"CC(C)(CS(=O)(=O)O)N(Cl)Cl","inchiKey":"QYNRGGHZWCUZLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AURICLOSENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Auriclosene","NVC-422","Nvc-422"],"crossReferences":{"drugbank":["DB12197"]},"childChemblIds":["CHEMBL453144","CHEMBL4297434"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1229967","canonicalSmiles":"CC1(C)N[C@H](C(=O)O)CS1","inchiKey":"OCQICQZUUHJWGZ-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229967","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01635"],"chEBI":["39764"]},"childChemblIds":["CHEMBL3245367"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230612","canonicalSmiles":"CCN(C(=O)c1cc(C)cc(OC[C@H](C)Nc2ccncc2)c1)C(C)C","inchiKey":"JMPSZYHYDMQFEO-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230612","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07279"]},"childChemblIds":["CHEMBL3182786"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231518","canonicalSmiles":"COc1cc(O)c(C(=O)/C=C/c2ccc(O)cc2)cc1CC=C(C)C","inchiKey":"ZUGCRBMNFSAUOC-YRNVUSSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231518","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07500"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232164","canonicalSmiles":"O=C(O)CCCCCCCCC(=O)O","inchiKey":"CXMXRPHRNRROMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEBACIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208976","82387"],"drugbank":["DB07645"],"chEBI":["41865"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232236","canonicalSmiles":"CC(C)OP(C)(=O)OC(C)C","inchiKey":"WOAFDHWYKSOANX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPHOSPHONIC ACID DIISOPROPYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208910","144210792"],"drugbank":["DB02127"],"chEBI":["77325"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232411","canonicalSmiles":"COCCOC","inchiKey":"XTHFKEDIFFGKHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232411","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207618"],"drugbank":["DB01749"],"chEBI":["42263"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232562","canonicalSmiles":"CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"DNVPQKQSNYMLRS-APGDWVJJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGOSTEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ergosterol D"],"crossReferences":{"Wikipedia":["Ergosterol"],"drugbank":["DB04038"],"chEBI":["16933"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232770","canonicalSmiles":"O=C1C(O)=CC(=O)c2c(O)cc(O)cc21","inchiKey":"RROPNRTUMVVUED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVIOLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02521"],"chEBI":["42646"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232777","canonicalSmiles":"O=c1[nH]cnc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)n[nH]c12","inchiKey":"MTCJZZBQNCXKAP-KSYZLYKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMYCIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04198"],"chEBI":["42654"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232971","canonicalSmiles":"O=C(/C=C/c1ccc(Cl)cc1)NO","inchiKey":"YPYUWBDOEMPXSK-ZZXKWVIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232971","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07819"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233129","canonicalSmiles":"CSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O","inchiKey":"QTQDDTSVRVWHMO-BQBZGAKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-METHYLGLUTATHIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04701"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235151","canonicalSmiles":"NCc1[nH]cc(CCC(=O)O)c1CC(=O)O","inchiKey":"QSHWIQZFGQKFMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235151","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02272"],"chEBI":["17381"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1254771","canonicalSmiles":"COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1","inchiKey":"AMTQCENHQIDBHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAFOTIBANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fov2304","LF22-0542","Safotibant"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1258517","canonicalSmiles":"O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1","inchiKey":"WXUUCRLKXQMWRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PKI-179","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PKI-179","Pki-179"],"count":1,"linkedTargets":{"rows":["ENSG00000121879","ENSG00000198793"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1356342","canonicalSmiles":"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)[O-].O.[Na+]","inchiKey":"IRGJMZGKFAPCCR-LTCKWSDVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1356342","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1544","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56422785"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1404","canonicalSmiles":"COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1","inchiKey":"XKLMZUWKNUAPSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANOLAZINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ranexa","Ranolazine"],"synonyms":["CVT-303","RS-43285-003","Ranolazine"],"crossReferences":{"DailyMed":["ranolazine"],"PubChem":["104171232","170465435","174006299","26749060","26749061","50107515","56463697","90340842"],"Wikipedia":["Ranolazine"],"drugbank":["DB00243"],"chEBI":["87690"]},"childChemblIds":["CHEMBL1526084","CHEMBL537649"],"count":15,"approvedIndications":["EFO_0000319","EFO_0003913"],"linkedTargets":{"rows":["ENSG00000183873","ENSG00000007314"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003086","MONDO_0005149","EFO_0001361","EFO_0009276","EFO_0000275","EFO_0000555","EFO_0001645","EFO_0000319","EFO_0000538","HP_0001657","EFO_0000384","Orphanet_684","EFO_0003913","EFO_0000195","EFO_1001375","EFO_0000253","MONDO_0011377","EFO_0001360","EFO_0000407","EFO_0005672","EFO_0004264","EFO_1000899","HP_0001653"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for angina pectoris and cardiovascular disease and has 13 investigational indications."}
{"id":"CHEMBL1486","canonicalSmiles":"CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O","inchiKey":"VCMJCVGFSROFHV-WZGZYPNHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENOFOVIR DISOPROXIL FUMARATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1538","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tenofovir disoproxil fumarate","Viread"],"synonyms":["GS-1278","GS-4331-05","GS-4331-05-","GSK-548470","GSK548470","PMPA","PMPA PRODRUG","PMPA Prodrug","PMPA-PRODRUG","Tenofovir","Tenofovir disoproxil fumarate","Viread"],"crossReferences":{"DailyMed":["tenofovir%20disoproxil%20fumarate"],"PubChem":["144207176"],"chEBI":["63718"]},"count":13,"approvedIndications":["EFO_0000544","EFO_0000764","EFO_0000180","EFO_0004197","EFO_0004239"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 5 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1568","canonicalSmiles":"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"HBUBKKRHXORPQB-FJFJXFQQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDARABINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Fluoro-Ara-A","Fludarabine"],"crossReferences":{"PubChem":["144206348","144206969","170464764","855645"],"Wikipedia":["Fludarabine"],"drugbank":["DB01073"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1607273","canonicalSmiles":"Cl.Cl.O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"PGLIUCLTXOYQMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETIRIZINE HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1000","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allacan","Allertek","Becoallergy","Cetec","Cetirizine hydrochloride","Cetirizine hydrochloride allergy","Cetirizine hydrochloride hives","Cetirizine hydrochloride hives relief","Cetirocol","Children's cetirizine hydrochloride allergy","Children's cetirizine hydrochloride hives relief","Children's zyrtec allergy","Children's zyrtec hives relief","Piriteze","Pollenshield","Quzyttir","Zerviate","Ziralton","Zirtek","Zynor","Zyrtec","Zyrtec allergy","Zyrtec hives relief"],"synonyms":["Cetirizine","Cetirizine dihydrochloride","Cetirizine hydrochloride","P 071","P-071","Zyrtec"],"crossReferences":{"DailyMed":["cetirizine%20hydrochloride"],"PubChem":["144204255","144212578","170465442","26749066"]},"count":5,"approvedIndications":["EFO_0005854","EFO_0005531","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003885","EFO_0005531","EFO_0003830","EFO_0003956","EFO_0003785"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1628385","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CCN(CC)CCOC(=O)c1ccc(N)cc1","inchiKey":"WHRVRSCEWKLAHX-LQDWTQKMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCAINE BENZYLPENICILLIN","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bicillin","Cilicaine syringe","Depocillin"],"synonyms":["E707","Procaine benzylpenicillin"],"crossReferences":{"DailyMed":["penicillin%20g%20procaine"],"DrugCentral":["4459"],"Wikipedia":["Procaine_benzylpenicillin"],"drugbank":["DB09320"],"chEBI":["52154"]},"childChemblIds":["CHEMBL1200936"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1948 and is indicated for bacterial disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL16293","canonicalSmiles":"c1ccc2ccccc2c1","inchiKey":"UFWIBTONFRDIAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPHTHALENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-37565","Naphthalene"],"crossReferences":{"PubChem":["144204574","144209202","144210328","17389811","225144198","26752807","49816690"],"Wikipedia":["Naphthalene"],"chEBI":["16482"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL164138","canonicalSmiles":"N=C(N)NCCC[C@H](NC(=O)C1CCCC1)C(=O)c1nc2ccccc2s1","inchiKey":"NQABUEUFRXDDFI-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL164138","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03251"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697837","canonicalSmiles":"CN(CC(=O)N1CCOCC1)Cc1c(Cl)cccc1NC(=O)c1ccccc1","inchiKey":"KSNNEUZOAFRTDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOMINOBEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fominoben","Fominoben hydrochloride","PB 89 [AS HYDROCHLORIDE]"],"crossReferences":{"drugbank":["DB08968"]},"childChemblIds":["CHEMBL2356122"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1789844","drugType":"Antibody","blackBoxWarning":false,"name":"IPILIMUMAB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Yervoy"],"synonyms":["BMS-734016","Ipilimumab","MDX-010","MDX-010 MDX-CTLA4","MDX-101","MDX-CTLA-4"],"crossReferences":{"DailyMed":["ipilimumab"],"DrugCentral":["4958"]},"count":87,"approvedIndications":["EFO_0000616","EFO_0000389","EFO_0000756","EFO_0002617","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000163599"],"count":1},"linkedDiseases":{"rows":["EFO_1000403","EFO_0003891","EFO_0000365","EFO_0001075","EFO_0000558","EFO_0000756","EFO_0000681","MONDO_0045056","EFO_0000571","EFO_1000657","EFO_0005952","EFO_0000228","EFO_1000984","EFO_1001951","MONDO_0017582","EFO_0000588","EFO_0000339","EFO_0000096","EFO_0009709","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_1000251","EFO_0008528","MONDO_0020634","Orphanet_2495","EFO_0000198","EFO_0002618","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_1001512","MONDO_0004669","EFO_1001968","MONDO_0008315","EFO_0001663","EFO_1000344","MONDO_0002691","MONDO_0015917","EFO_0001061","MONDO_0002547","MONDO_0000544","EFO_0004284","EFO_0008524","EFO_0000574","EFO_0006544","EFO_0001378","EFO_1000613","EFO_0000563","EFO_0001376","MONDO_0009348","EFO_1001972","MONDO_0015686","MONDO_0045069","EFO_1001465","MONDO_0007254","EFO_0000708","MONDO_0021063","MONDO_0002087","MONDO_0024879","EFO_0004252","EFO_0000305","EFO_0003085","MONDO_0001187","MONDO_0001056","EFO_1001480","EFO_1000044","Orphanet_377","EFO_0007466","EFO_1001974","EFO_0000770","EFO_0000196","EFO_0000673","MONDO_0020743","EFO_0000183","EFO_0004193","EFO_0002617","EFO_0000616","EFO_0006859","EFO_1000616","EFO_0002916","EFO_0000503","EFO_1000314","EFO_0000403","Orphanet_44890","EFO_0000222","MONDO_0007576","EFO_0000313","EFO_0004243","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0003863","EFO_1001471","EFO_0000304","MONDO_0002120","EFO_0000095","EFO_0000764","EFO_0002517","EFO_0000702","MONDO_0002367","MONDO_0003219","EFO_1000081","MONDO_0024880","EFO_1001927","EFO_0000181","EFO_0000519","EFO_1001950","EFO_0000691"],"count":110},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 5 approved and 82 investigational indications."}
{"id":"CHEMBL186141","canonicalSmiles":"C=C1CC[C@H]2[C@@](C)(CC[C@@H](O)[C@@]2(C)CO)[C@@H]1C/C=C1/C(=O)OC[C@H]1O","inchiKey":"BOJKULTULYSRAS-OTESTREVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROGRAPHOLIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Andrographolide","HMPL-004","HMPL004","NSC-383468"],"crossReferences":{"PubChem":["144205061"],"drugbank":["DB05767"],"chEBI":["65408"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL186179","canonicalSmiles":"COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1","inchiKey":"IRLWJILLXJGJTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MURAGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-298585","BMS-298585-01","MK-0478","MK0478","Muraglitazar"],"crossReferences":{"PubChem":["170466259"],"drugbank":["DB06510"]},"childChemblIds":["CHEMBL3527055","CHEMBL557580"],"count":3,"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400","Orphanet_309005"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1874205","canonicalSmiles":"CC(O)(P(=O)(O)O)P(=O)(O)O.O","inchiKey":"KKNZXUHBWLPUFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1874205","maximumClinicalTrialPhase":0,"parentId":"CHEMBL871","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211688","26754462"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908371","canonicalSmiles":"CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"MVPQUSQUURLQKF-ABIFMKGDSA-E","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"IDRAPARINUX SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1908845","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idraparinux nonasodium salt","Idraparinux sodium","ORG-34006","SANORG-34006","SANORG34006"],"count":3,"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003827","EFO_0003907"],"count":3},"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1909285","canonicalSmiles":"Cc1nc([N+](=O)[O-])cn1-c1ccc([N+](=O)[O-])cc1","inchiKey":"NMTBSNPBIGRZBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITREFAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Hematological toxicity"," Hepatotoxicity"],"year":1984},"tradeNames":[],"synonyms":["EMD 15 700","Nitrefazole"],"crossReferences":{"PubChem":["144206859"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1984 due to Hematological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL191","canonicalSmiles":"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1","inchiKey":"PSIFNNKUMBGKDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOSARTAN","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["HGP-1405","HGP1405","Losartan"],"crossReferences":{"DailyMed":["losartan%20potassium"],"PubChem":["144204988","170465135","26748956"],"Wikipedia":["Losartan"],"drugbank":["DB00678"],"chEBI":["6541"]},"childChemblIds":["CHEMBL367465","CHEMBL995"],"count":33,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000729","EFO_0000637","EFO_0000275","Orphanet_232","EFO_0003095","EFO_0000401","EFO_0000768","EFO_0000464","EFO_1001249","Orphanet_586","EFO_0000373","MONDO_0002462","EFO_0000538","EFO_1000637","EFO_1000653","Orphanet_416","EFO_0003144","EFO_0004253","EFO_0003884","EFO_1002032","EFO_0009321","EFO_0002617","EFO_0000694","EFO_0002618","MONDO_0005149","HP_0002140","HP_0000093","EFO_0001645","EFO_0000180","EFO_0001358","EFO_0000319","EFO_0004194","EFO_0004236","Orphanet_558","EFO_0000384","EFO_0000537","EFO_0004232","EFO_0000546","EFO_0003896","GO_0007568","MP_0001845","MONDO_0100096","EFO_0006818","EFO_0001359","EFO_0002517","EFO_0006505","EFO_0000764","EFO_0001360","EFO_0000519","EFO_0000668","EFO_0004265"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for cardiovascular disease and has 32 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1910856","canonicalSmiles":"CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC(Oc2cccc(O)c2)C1","inchiKey":"WGOJWDWKHJHXSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03635659","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-3635659","PF03635659","Pf-03635659","Pf03635659"],"crossReferences":{"drugbank":["DB12408"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL191632","canonicalSmiles":"Nc1cncc(Cl)n1","inchiKey":"JTPXVCKCLBROOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191632","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02297"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL197865","canonicalSmiles":"O=C1O/C(=C\\c2cccc3ccccc23)C(O)=C1c1ccc(Cl)cc1","inchiKey":"PLGHLEBIWUQEPR-PDGQHHTCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL197865","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07296"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL204785","canonicalSmiles":"COc1ccc(NCCNC(=O)[C@H](CC2CCCCC2)Nc2nc3ccccc3o2)cc1","inchiKey":"VFNWTXUFNNOQHD-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL204785","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07839"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2048484","canonicalSmiles":"Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1","inchiKey":"XTNGUQKDFGDXSJ-ZXGKGEBGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CANAGLIFLOZIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Canagliflozin","JNJ-24831754-ZAE","JNJ-28431754","JNJ-28431754-AAA","TA-7284"],"crossReferences":{"DailyMed":["canagliflozin"],"drugbank":["DB08907"],"chEBI":["73274"]},"childChemblIds":["CHEMBL4594217","CHEMBL2103841"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0003144","EFO_0000401","EFO_0001359","EFO_0004194","EFO_0001360","EFO_0000400","EFO_0001073"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2059073","canonicalSmiles":"COc1cc(O)c(C(=O)c2ccccc2)cc1S(=O)(=O)O","inchiKey":"CXVGEDCSTKKODG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULISOBENZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sungard"],"synonyms":["Sulisobenzone"],"crossReferences":{"PubChem":["144205192","144209530","144213779","170465489"],"drugbank":["DB11185"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103856","canonicalSmiles":"CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2","inchiKey":"QWKAUGRRIXBIPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATOPAXAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atopaxar","E-5555","E5555","ER-172594-00"],"crossReferences":{"drugbank":["DB12046"]},"childChemblIds":["CHEMBL2105699"],"count":1,"linkedTargets":{"rows":["ENSG00000181104"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0005672"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2103963","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O.CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+].c1ccc(CNCCNCc2ccccc2)cc1","inchiKey":"MKWCVIJOIUPXTC-ZLOILWTKSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BICILLIN V2","maximumClinicalTrialPhase":0,"parentId":"CHEMBL615","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bicillin v2"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103991","canonicalSmiles":"Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O","inchiKey":"IETKPTYAGKZLKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALAGLITAZONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balaglitazone","DRF-2593","Drf-2593","NN-2344"],"crossReferences":{"drugbank":["DB12781"]},"count":1,"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104273","canonicalSmiles":"CCN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2","inchiKey":"PHTMLLGDZBZXMW-AERCQKQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYBENZTROPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Panolid"],"synonyms":["Ethybenztropine","Etybenzatropine","UK-738"],"crossReferences":{"drugbank":["DB13468"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104612","canonicalSmiles":"O[C@H](CBr)[C@H](O)[C@H](O)[C@@H](O)CBr","inchiKey":"VFKZTMPDYBFSTM-GUCUJZIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOLACTOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibromodulcitol","Mitolactol","NCI-C04795","NSC-104800"],"crossReferences":{"drugbank":["DB12916"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105044","canonicalSmiles":"CCOC(=O)CSCCC1NC(C(=O)O)CS1","inchiKey":"IKOCLISPVJZJEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETOSTEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Letosteine"],"crossReferences":{"drugbank":["DB08939"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105611","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CC[C@@H](O)C(C)C)C[C@@H](O)C[C@@H]1O","inchiKey":"BJYLYJCXYAMOFT-RSFVBTMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TACALCITOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Curatoderm"],"synonyms":["Tacalcitol"],"crossReferences":{"drugbank":["DB13689"]},"count":2,"approvedIndications":["EFO_1001494","EFO_0000676"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psoriasis vulgaris and psoriasis."}
{"id":"CHEMBL2105641","canonicalSmiles":"CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)[N-]S(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F.[K+]","inchiKey":"PPADHTVWIWCEDE-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ELINOGREL POTASSIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103828","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elinogrel potassium","PRT060128-POTASSIUM"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105706","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCCCC(=O)O[C@H]2CN3CCC2CC3)C[C@@H]1OC.Cl.Cl","inchiKey":"ZKVOMYDQQYOJKE-HTKGJVFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NARONAPRIDE DIHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103858","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-7505 2HCL","ATI-7505 BIS HCL","Naronapride dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105760","canonicalSmiles":"O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1","inchiKey":"ZKIAIYBUSXZPLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BREXPIPRAZOLE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rexulti"],"synonyms":["Brexpiprazole","OPC-34712"],"crossReferences":{"DailyMed":["brexpiprazole"],"drugbank":["DB09128"]},"count":10,"approvedIndications":["MONDO_0002009","EFO_0003761","EFO_0005407","EFO_0000692","EFO_0005411"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000102468"],"count":3},"linkedDiseases":{"rows":["HP_0012076","MONDO_0002009","EFO_0000249","EFO_0009963","EFO_0005407","EFO_0001358","EFO_0008568","EFO_0003829","HP_0000713","EFO_0000289","MONDO_0002050","EFO_0003761","EFO_0000692","EFO_0005411"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105764","canonicalSmiles":"CC1=C2C[C@H]3[C@@H](CC[C@@H]4C[C@H](NS(C)(=O)=O)CC[C@]34C)[C@@H]2CC[C@@]2(C1)O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C.Cl","inchiKey":"LICVMCOINZNZNW-BATHLIJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PATIDEGIB HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL538867","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPI-926","Patidegib hydrochloride","Saridegib hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2106574","canonicalSmiles":"CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1.Cl","inchiKey":"IHWDIQRWYNMKFM-BDQAORGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPOXETINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110900","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Priligy"],"synonyms":["Dapoxetine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2106636","canonicalSmiles":"CCCCNCC(O)c1ccc(O)cc1.CCCCNCC(O)c1ccc(O)cc1.O=S(=O)(O)O","inchiKey":"PARMADWNFXEEFC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMETHAN SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1987462","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vasculit"],"synonyms":["Bamethan sulf","Bamethan sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2106873","canonicalSmiles":"O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Mg+2].[Mg+2].[Mg+2]","inchiKey":"GVALZJMUIHGIMD-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM PHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"DrugCentral":["4596"],"drugbank":["DB13862"]},"childChemblIds":["CHEMBL3989627"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107324","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(N)=O","inchiKey":"GBONBLHJMVUBSJ-FAUHKOHMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CORTICORELIN ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Xerecept"],"synonyms":["Corticorelin acetate","NEU 3002","NEU-3002 ACETATE"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108285","drugType":"Antibody","blackBoxWarning":false,"name":"CAPROMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Capromab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109508","drugType":"Antibody","blackBoxWarning":false,"name":"IMMURAIT-LL2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMMURAIT-LL2"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146100","canonicalSmiles":"CN(C)[C@@H]1C([O-])=C(C(N)=O)C(=O)[C@@]2(O)C([O-])=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12.[Ca+2]","inchiKey":"MAWUOYRJAIQZRH-MRFRVZCGSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORTETRACYCLINE CALCIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL404520","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlortetracycline calcium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL231616","canonicalSmiles":"NC(=S)N/N=C/c1ncccc1N","inchiKey":"XMYKNCNAZKMVQN-NYYWCZLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-AP","NSC-663249","OCX-0191","OCX-191","Ocx 191","PAN-811","Triapine"],"crossReferences":{"PubChem":["510133"],"Wikipedia":["3-Aminopyridine-2-carboxaldehyde_thiosemicarbazone"],"drugbank":["DB11940"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2354444","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@@H]2CCCCO2)[C@H](C)O1","inchiKey":"KMSKQZKKOZQFFG-YXRRJAAWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRARUBICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pirarubicin"],"crossReferences":{"PubChem":["144206155","170465822"],"drugbank":["DB11616"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2355333","canonicalSmiles":"CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1.Cl.Cl.O","inchiKey":"WFUAVXYXJOQWAZ-GVKRCPFFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIMELDINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL37744","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom, Germany"],"classes":["Hepatotoxicity"],"year":1983},"tradeNames":[],"synonyms":["H 102/09 HYDROCHLORIDE","Zimeldine hydrochloride","Zimelidine hydrochloride"],"crossReferences":{"PubChem":["144204841","170466366"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom, Germany  in 1983 due to Hepatotoxicity."}
{"id":"CHEMBL2362557","canonicalSmiles":"Cl.c1ccc2c(CCC3CCNCC3)c[nH]c2c1","inchiKey":"GIPICJLTGNEIIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2362557","maximumClinicalTrialPhase":0,"parentId":"CHEMBL276520","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206865"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364608","canonicalSmiles":"Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O","inchiKey":"ZIAOVIPSKUPPQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORAVIRINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pifeltro"],"synonyms":["Doravirine","MK-1439"],"crossReferences":{"DailyMed":["doravirine"],"drugbank":["DB12301"]},"count":4,"approvedIndications":["EFO_0000764","EFO_0000180","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL2364614","canonicalSmiles":"CN1Cc2cc(-c3ccc(N)nn3)ccc2[C@H](c2ccc3ccccc3c2)C1","inchiKey":"VCIBGDSRPUOBOG-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIAFENSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-820836","Liafensine"],"crossReferences":{"drugbank":["DB14878"]},"count":1,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["MONDO_0002050"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2364628","canonicalSmiles":"O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO","inchiKey":"QGZYDVAGYRLSKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RICOLINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACY-1215","ACY-63","Ricolinostat"],"crossReferences":{"drugbank":["DB12376"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2386601","canonicalSmiles":"CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](NCCCNCCCCN)C[C@@H]1C[C@H]3O)OS(=O)(=O)O.CC(O)C(=O)O","inchiKey":"JMNXSNUXDHHTKQ-VLHVCALYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2386601","maximumClinicalTrialPhase":0,"parentId":"CHEMBL444929","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2403318","canonicalSmiles":"Cn1c(C2(NC(=O)c3ccc4c(C5CCCC5)c(-c5ncc(Br)cn5)n(C)c4c3)CCC2)nc2ccc(/C=C/C(=O)O)cc21","inchiKey":"BMAIGAHXAJEULY-UKTHLTGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELEOBUVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 207127","BI-207127","Deleobuvir"],"crossReferences":{"drugbank":["DB14850"]},"childChemblIds":["CHEMBL3137315"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL262636","canonicalSmiles":"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.[Na+]","inchiKey":"SCLZRKVZRBKZCR-SLINCCQESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OXACILLIN SODIUM SALT","maximumClinicalTrialPhase":0,"parentId":"CHEMBL891","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRL-1621"],"crossReferences":{"PubChem":["144204295","170465404","56463563"],"chEBI":["51357"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL264373","canonicalSmiles":"Cc1nc(N)nc(N)c1-c1ccc(Cl)c(Cl)c1","inchiKey":"VQJHOPSWBGJHQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOPRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metoprine","TCMDC-123931"],"crossReferences":{"PubChem":["170466776","73253","92763928"],"drugbank":["DB04655"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27193","canonicalSmiles":"C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1","inchiKey":"SGUAFYQXFOLMHL-ACJLOTCBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILEVALOL","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hepatotoxicity"],"year":1990},"tradeNames":[],"synonyms":["Dilevalol"],"childChemblIds":["CHEMBL1204165"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990. It was withdrawn in United Kingdom  in 1990 due to Hepatotoxicity."}
{"id":"CHEMBL30044","canonicalSmiles":"N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2Br)c(Br)c1","inchiKey":"GMJFVGRUYJHMCO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBROMPROPAMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibrompropamidine"],"crossReferences":{"PubChem":["124899409"],"Wikipedia":["Dibrompropamidine"],"drugbank":["DB13548"]},"childChemblIds":["CHEMBL2360824","CHEMBL3277938"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL301370","canonicalSmiles":"CC[C@H]1C(=O)Nc2ccc(F)cc2N1C(=O)OC(C)C","inchiKey":"KELNNWMENBUHNS-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OPAVIRALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Opaviraline"],"crossReferences":{"drugbank":["DB07884"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303041","canonicalSmiles":"CC(C)c1sc(NC(=O)c2cc(NC(=O)c3cc(NC=O)cn3C)cn2C)nc1C(=O)NCCCN(C)C","inchiKey":"VDYCDKRATGWFDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL303041","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137340","drugType":"Cell","blackBoxWarning":false,"name":"VIAGENPUMATUCEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HS-110","Viagenpumatucel l","Viagenpumatucel-l"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3185794","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O=S(=O)(O)O","inchiKey":"HOBWAPHTEJGALG-AADVZIIPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185794","maximumClinicalTrialPhase":0,"parentId":"CHEMBL517712","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210044"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL324168","canonicalSmiles":"N=C(N)c1ccc2cc(C(=O)Nc3ccc(CN)cc3)ccc2c1","inchiKey":"NLBDETRVUYOIHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL324168","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02398"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3311228","canonicalSmiles":"O[C@@](Cn1cnnn1)(c1ccc(F)cc1F)C(F)(F)c1ccc(-c2ccc(OCC(F)(F)F)cc2)cn1","inchiKey":"IDUYJRXRDSPPRC-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTESECONAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oteseconazole","VT-1161","Vt-1161"],"crossReferences":{"drugbank":["DB13055"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL339231","canonicalSmiles":"CO[C@H]1/C=C\\C=C(/C)C(=O)NC2=CC(=O)C(N)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@@H]1OC(N)=O)C2=O","inchiKey":"XYFFWTYOFPSZRM-TWNAANEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL339231","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13023"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL339611","canonicalSmiles":"CCSc1cc(OC)c(CC(C)N)cc1OC","inchiKey":"MCYCODJKXUJSAT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL339611","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13940"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL343336","canonicalSmiles":"O=C(O)CCCn1c2c(c3ccccc3c1=O)C(=O)c1ccccc1-2","inchiKey":"AHIJTWCJGCWHMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL343336","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08159"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3526209","canonicalSmiles":"O=C(c1ccc(F)c(F)c1N[14c]1[14cH][14cH][14c](I)[14cH][14c]1F)N1CC(O)([C@@H]2CCCCN2)C1","inchiKey":"BSMCAPRUBJMWDF-NZZZTBTLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526209","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2146883","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545094","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@@H](C)C/C=C/C(O)(CC)CC)=CCC23)C[C@@H](O)C[C@@H]1O","inchiKey":"XDBOQJCMEXOPMU-BAHYQGKPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELOCALCITOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bxl-628","Elocalcitol","Ro-26-9228"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545308","canonicalSmiles":"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1","inchiKey":"HUFOZJXAKZVRNJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCILETINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVL-301","CNX-419","CO-1686","CS-1631","Rociletinib"],"crossReferences":{"drugbank":["DB11907"]},"count":2,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3560765","canonicalSmiles":"O=P([O-])(O)C(O)(Cc1cccnc1)P(=O)([O-])O.[Na+].[Na+]","inchiKey":"ARGHCEVMLACPSI-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3560765","maximumClinicalTrialPhase":0,"parentId":"CHEMBL923","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170464992"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL361506","canonicalSmiles":"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO","inchiKey":"YBVNFKZSMZGRAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAMIDINE ISETHIONATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL55","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nebupent","Pentacarinat","Pentam","Pentamidine isethionate"],"synonyms":["MB 800","OCZ103-OS","Pentamidine diisethionate","Pentamidine isethionate","Pentamidine isetionate","RP 2512"],"crossReferences":{"DailyMed":["pentamidine%20isethionate"],"PubChem":["144204293","144208920","144210632","170464786"],"chEBI":["7977"]},"count":5,"approvedIndications":["DOID_10113","EFO_0005044"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for trypanosomiasis and leishmaniasis and has 3 investigational indications."}
{"id":"CHEMBL3707351","canonicalSmiles":"Cc1cc(O[C@@H](CCC(F)(F)F)c2ccc(C(=O)NCCC(=O)O)cc2)cc(C)c1-c1ccc(C(C)(C)C)cc1","inchiKey":"FASLTMSUPQDLIB-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADOMEGLIVANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adomeglivant","LY-2409021","LY2409021","Ly2409021"],"crossReferences":{"drugbank":["DB11704"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707374","canonicalSmiles":"CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F.Cl","inchiKey":"GEDVJGOVRLHFQG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMISELIMOD HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3707375","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amiselimod hydrochloride","MT-1303"],"count":5,"linkedTargets":{"rows":["ENSG00000170989","ENSG00000180739","ENSG00000267534","ENSG00000213694","ENSG00000125910"],"count":5},"linkedDiseases":{"rows":["EFO_0002690","EFO_0000676","EFO_0003929","EFO_0000384","EFO_0003767"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL370753","canonicalSmiles":"OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1","inchiKey":"YNZFUWZUGRBMHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OPIPRAMOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-169867","Opipramol"],"crossReferences":{"PubChem":["26755651","29216400","90341209"],"Wikipedia":["Opipramol"],"drugbank":["DB12930"]},"childChemblIds":["CHEMBL1524185"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL373357","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O","inchiKey":"NVKAWKQGWWIWPM-MISPCMORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL373357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56314652"],"drugbank":["DB07447"],"chEBI":["2150"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL374385","canonicalSmiles":"CC(=O)Oc1ccccc1C(=O)Oc1cccc(CO[N+](=O)[O-])c1","inchiKey":"IOJUJUOXKXMJNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NCX-4016","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ncx-4016","Nitroaspirin"],"crossReferences":{"drugbank":["DB12445"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL376140","canonicalSmiles":"CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O","inchiKey":"FPZLLRFZJZRHSY-HJYUBDRYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TIGECYCLINE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tigecycline","Tygacil"],"synonyms":["Tigecycline","WAY-GAR-936"],"crossReferences":{"DailyMed":["tigecycline"],"PubChem":["144206463"],"Wikipedia":["Tigecycline"],"drugbank":["DB00560"],"chEBI":["149836"]},"count":12,"approvedIndications":["EFO_0000771","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for infection and bacterial disease and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL376359","canonicalSmiles":"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O","inchiKey":"ZSBOMTDTBDDKMP-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOGLIPTIN","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vipidia"],"synonyms":["Alogliptin"],"crossReferences":{"DailyMed":["alogliptin%20benzoate"],"Wikipedia":["Alogliptin"],"drugbank":["DB06203"],"chEBI":["72323"]},"childChemblIds":["CHEMBL227529","CHEMBL458537","CHEMBL459806"],"count":2,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for diabetes mellitus and has 1 investigational indication."}
{"id":"CHEMBL3833316","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(=O)c3cc(=O)[nH]c(=O)[nH]3)C[C@@H](C(=O)NCCNC(=O)COCCOCC(=O)Nc3cc(S(=O)(=O)[O-])cc4cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c34)C[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)[O-])[C@H]2OC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O.[Na+].[Na+].[Na+].[Na+]","inchiKey":"QQDCIMVGFXSAJH-DJFGCAFRSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVIPANSEL SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3707446","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GMI-1070","PF-06460031-02","PF-0646003102","Rivipansel sodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL39","canonicalSmiles":"NCCc1c[nH]c2ccc(O)cc12","inchiKey":"QZAYGJVTTNCVMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEROTONIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-HT","5-Hydroxytryptamine","Serotonin"],"crossReferences":{"PubChem":["11111288","11111289","124880365","26754231","26754232","26754233","26755328","50109811","50109812","90341122"],"Wikipedia":["Serotonin"],"drugbank":["DB08839"],"chEBI":["28790"]},"childChemblIds":["CHEMBL535832"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL391805","canonicalSmiles":"CN1CCc2nc(C(=O)N[C@@H]3CCCC[C@H]3NC(=O)c3cc4cc(Cl)ccc4[nH]3)sc2C1","inchiKey":"ARPFWVKYXJZULB-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391805","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07630"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989564","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O.NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"NZKFUBQRAWPZJP-BXKLGIMVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOBRAMYCIN SULFATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1747","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nebcin","Tobramycin sulfate","Tobramycin sulfate (pharmacy bulk)"],"synonyms":["Tobramycin sulfate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1975 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989823","canonicalSmiles":"NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2C[C@H](O)NC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O.O=S(=O)(O)O","inchiKey":"AQONYROJHRNYQQ-QMAPKBLTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VIOMYCIN SULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3085436","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Viocin sulfate"],"synonyms":["Viomycin sulfate"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3989850","canonicalSmiles":"CC1(C)C2CCC1(CS(=O)(=O)O)C(=O)C2=Cc1ccc(C=C2C(=O)C3(CS(=O)(=O)O)CCC2C3(C)C)cc1","inchiKey":"HEAHZSUCFKFERC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECAMSULE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mexoryl SX"],"synonyms":["Ecamsule"],"crossReferences":{"drugbank":["DB09534"]},"childChemblIds":["CHEMBL4303168"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2006."}
{"id":"CHEMBL3989859","canonicalSmiles":"CC(=O)Oc1c(C)c(C)c2c(c1C)CCC(C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"ZAKOWWREFLAJOT-ADUHFSDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOCOPHEROL ACETATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["E-tabs","E-vicotrat","Ephynal"],"synonyms":["Alpha-tocopherol acetate","Tocopherol acetate","Tocopheryl acetate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and has 1 investigational indication."}
{"id":"CHEMBL3990029","drugType":"Antibody","blackBoxWarning":false,"name":"RISANKIZUMAB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Skyrizi"],"synonyms":["655066-01","ABBV-066","BI655066","Risankizumab","Risankizumab-rzaa"],"crossReferences":{"DailyMed":["risankizumab-rzaa"]},"count":9,"approvedIndications":["EFO_0000676","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000110944"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000710","EFO_1001494","MONDO_0100096","EFO_0000270","EFO_0003898","MONDO_0002406","EFO_0003778","EFO_0000676","Orphanet_163927","EFO_0000540","EFO_0000384"],"count":12},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for immune system disease and psoriasis and has 7 investigational indications."}
{"id":"CHEMBL403664","canonicalSmiles":"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1","inchiKey":"OYVAGSVQBOHSSS-UAPAGMARSA-O","drugType":"Small molecule","blackBoxWarning":true,"name":"BLEOMYCIN","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bleo-kyowa"],"synonyms":["Bleomycin","Bleomycin hydrochloride","Bleomycins","NSC-125066"],"crossReferences":{"Wikipedia":["Bleomycin"],"chEBI":["3139"]},"childChemblIds":["CHEMBL3085504"],"count":4,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for neoplasm and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4063359","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1","inchiKey":"ZAANCPPIXAWPTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4063359","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4112929","canonicalSmiles":"C[C@@H]1CCC[C@H](n2cnc(-c3cc(Cl)ccc3-n3cc(Cl)nn3)cc2=O)c2cc(ccn2)-c2c(cnn2C(F)F)NC1=O","inchiKey":"FSWFYCYPTDLKON-CMJOXMDJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILVEXIAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS 986177","BMS-986177","Bms-986177","JNJ-70033093","Jnj-70033093","Milvexian"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL42039","canonicalSmiles":"CCNC(=O)COc1ccc(Cl)cc1CNC(=O)[C@@H]1CCCN1C(=O)[C@H](N)C1CCCCC1","inchiKey":"BMHVHOJXEQTIEA-SIKLNZKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL42039","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06869"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425181","canonicalSmiles":"CCc1nn(-c2c(Cl)cc(Cl)cc2Cl)c2nc(Cc3ccc(O)c(O)c3)[nH]c(=O)c12","inchiKey":"OPRAIFVPXXVXDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425181","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07606"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297219","canonicalSmiles":"C[C@H]1CN(C(=O)c2ccc(NC(=O)c3cc(O[C@H](C)c4c(Cl)ccc(F)c4Cl)c(N)nn3)cc2)C[C@@H](C)N1.Cl.Cl","inchiKey":"IERUINQRGJAECT-ISUJJMBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENSARTINIB HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4113131","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ensartinib hydrochloride","X-396 HCl"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297278","canonicalSmiles":"CC[C@H](O)[C@@H](C)[C@H]1O[C@@H]1C[C@@](C)(O)/C=C/C=C(\\C)[C@H]1OC(=O)C[C@H](O)CC[C@@](C)(O)[C@@H](OC(=O)N2CCN(C3CCCCCC3)CC2)/C=C/[C@@H]1C","inchiKey":"MNOMBFWMICHMKG-MGYWSNOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E7107","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E7107"],"crossReferences":{"drugbank":["DB12508"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297316","canonicalSmiles":"CCC[C@@H](C)C[C@H](CN)CC(=O)O","inchiKey":"KKXFMWXZXDUYBF-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-0299685","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD 0299685","Pd-0299685"],"crossReferences":{"drugbank":["DB15264"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297472","canonicalSmiles":"CN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C(=S)[S-].[Na+]","inchiKey":"PLQRBFAACWRSKF-LJTMIZJLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NOX-100","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4301787","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NOX-100","Nox-100"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297483","canonicalSmiles":"CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1","inchiKey":"ZNKWRAKPQQZLNX-ZDQHWEPJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8871","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-8871","AZD8871","Azd 8871","Azd-8871","Azd8871","LAS-191351","LAS191351","Navafenterol"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297577","drugType":"Unknown","blackBoxWarning":false,"name":"BELAPECTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Belapectin","GR-MD-02","Gr-md-02"],"count":7,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297771","drugType":"Unknown","blackBoxWarning":false,"name":"INTERLEUKIN-10","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Il-10","Interleukin-10"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297960","drugType":"Unknown","blackBoxWarning":false,"name":"DAVANAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Davanat","GM-CT-01","Gm-ct-01"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297994","drugType":"Unknown","blackBoxWarning":false,"name":"TILSOTOLIMOD SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMO-2125 sodium","TLR9 AGONIST IMO-2125","Tilsotolimod sodium"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298086","drugType":"Antibody","blackBoxWarning":false,"name":"POZELIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pozelimab","REGN-3918","REGN3918","Regn3918"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL429844","canonicalSmiles":"CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O","inchiKey":"NTCCRGGIJNDEAB-IRXDYDNUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORE-1001","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GL1001","MLN-4760","ORE-1001 FREE ACID","ORE1001","Ore-1001","Ore1001"],"crossReferences":{"drugbank":["DB12271"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL43719","canonicalSmiles":"CCCCCCCNC=O","inchiKey":"YAUHDTOEJHVKJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTYLFORMAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Heptyl-Formamide"],"crossReferences":{"drugbank":["DB04105"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL439","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1","inchiKey":"SEEPANYCNGTZFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADIAZINE","yearOfFirstApproval":1941,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adiazine","Coco-diazine","Diazyl","Sulfadiazine","Sulfapyrimidine","Sulfolex","Sulphadiazine"],"synonyms":["NSC-35600","SSD","Sildaflo","Silvadene","Sulfacombin","Sulfadiazine","Sulfadiazine (trisulfapyrimidines)","Sulphadiazine","Thermazene"],"crossReferences":{"DailyMed":["silver%20sulfadiazine","sulfadiazine"],"PubChem":["11112193","144203911","855872"],"Wikipedia":["Sulfadiazine"],"drugbank":["DB00359"],"chEBI":["9328"]},"childChemblIds":["CHEMBL1200351","CHEMBL1200766","CHEMBL1382627"],"count":6,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1941 and is indicated for bacterial disease and has 5 investigational indications."}
{"id":"CHEMBL447629","canonicalSmiles":"O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr","inchiKey":"VFKZTMPDYBFSTM-KVTDHHQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOBRONITOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Myelobromol"],"synonyms":["DBM","Mitobronitol"],"crossReferences":{"PubChem":["144204630","144208362","29215109","46500622"],"Wikipedia":["Mitobronitol"],"drugbank":["DB13543"],"chEBI":["34853"]},"count":1,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for neoplasm."}
{"id":"CHEMBL4594536","drugType":"Unknown","blackBoxWarning":false,"name":"CS-1003","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS 1003","CS-1003","CS1003","Cs-1003","Cs1003"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL460287","canonicalSmiles":"C(COCCOCC1CO1)OCCOCC1CO1","inchiKey":"UMILHIMHKXVDGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOGLUCID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Epodyl"],"synonyms":["Ethoglucid","Etoglucid","ICI 32865"],"crossReferences":{"drugbank":["DB13339"],"chEBI":["82542"]},"count":1,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for neoplasm."}
{"id":"CHEMBL471144","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O","inchiKey":"GNZLUJQJDPRUTD-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5'-O-(Sulfamoyl)Adenosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-O-(Sulfamoyl)Adenosine","5'-O-Sulfamoyladenosine"],"crossReferences":{"drugbank":["DB02916"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL474579","canonicalSmiles":"CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)O)S2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21","inchiKey":"SRZNHPXWXCNNDU-IXOPCIAXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTETAN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefotan"],"synonyms":["Cefotetan","ICI 156,834","ICI-156834"],"crossReferences":{"DailyMed":["cefotetan%20disodium"],"PubChem":["144204232","56463651"],"Wikipedia":["Cefotetan"],"drugbank":["DB01330"],"chEBI":["3499"]},"childChemblIds":["CHEMBL1201098"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL50","canonicalSmiles":"O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12","inchiKey":"REFJWTPEDVJJIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUERCETIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C.I. Natural Red 1","LDN 0052529","LDN-0052529","Meletin","NSC 57655","NSC 9219","NSC-57655","NSC-9219","Quercetin","Sophoretin","Xanthaurine"],"crossReferences":{"PubChem":["11111704","11111705","11111706","11113933","124881262","124881263","124881264","124881266","124881267","124881272","124881274","144209506","144210605","26747157","26752084","26752085","26752086","50104737","50104738","50104739","50113478","50113479","50113480","50113481","74741","85231204","90341524","99460891"],"Wikipedia":["Quercetin"],"drugbank":["DB04216"],"chEBI":["16243"]},"childChemblIds":["CHEMBL1520590","CHEMBL1173475"],"count":10,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL503565","canonicalSmiles":"CC/C=C(\\C)C1(CC)C(=O)NC(=O)NC1=O","inchiKey":"RAFOHKSPUDGZPR-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINBARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butenemal","Vinbarbital","Vinbarbitone"],"crossReferences":{"Wikipedia":["Vinbarbital"],"drugbank":["DB13377"]},"childChemblIds":["CHEMBL2107295"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL538943","canonicalSmiles":"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"CILBMBUYJCWATM-UDRBCWGGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VINORELBINE TARTRATE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL553025","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Navelbine","Vinorelbine tartrate"],"synonyms":["TLC-178","TLC178","Vinorelbine Ditartarate","Vinorelbine ditartrate","Vinorelbine tartrate"],"crossReferences":{"DailyMed":["vinorelbine%20tartrate"],"PubChem":["144205824","170465330"]},"count":26,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_1000172","EFO_0003869","EFO_0004708","EFO_0000571","MONDO_0007254","MONDO_0021063","EFO_0005952","MONDO_0001187","EFO_0000565","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_0000183","EFO_0001416","EFO_0000616","MONDO_0001402","EFO_0000248","EFO_0000313","MONDO_0008315","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0006861","MONDO_0011962","EFO_0000233","EFO_0000574","MONDO_0002367","MONDO_0017386","MONDO_0002863","MONDO_0024880","EFO_0000691"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 26 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL591429","canonicalSmiles":"C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O","inchiKey":"YQNRVGJCPCNMKT-LFVJCYFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAC-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PAC-1","Pac-1"],"crossReferences":{"PubChem":["50112924","90341778"],"drugbank":["DB13048"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL605003","canonicalSmiles":"CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2","inchiKey":"LOGJQOUIVKBFGH-YBEGLDIGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-6656","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-6656"],"crossReferences":{"PubChem":["11111835","50106863","50106864","56463485","85231238"],"Wikipedia":["SU6656"],"drugbank":["DB08039"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL61733","canonicalSmiles":"Nc1nc(N)c2ncn(CCOCP(=O)(O)O)c2n1","inchiKey":"XHXFQGAZAVKMFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PMEDAP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08843"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL668","canonicalSmiles":"CNCCCC1c2ccccc2C=Cc2ccccc21","inchiKey":"BWPIARFWQZKAIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROTRIPTYLINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Protriptyline"],"crossReferences":{"DailyMed":["protriptyline%20hydrochloride"],"PubChem":["11111679","11111680","50100330","50104299","90341254"],"Wikipedia":["Protriptyline"],"drugbank":["DB00344"],"chEBI":["8597"]},"childChemblIds":["CHEMBL1200332"],"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL680","canonicalSmiles":"N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1","inchiKey":"QYIYFLOTGYLRGG-GPCCPHFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFACLOR","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceclor","Raniclor"],"synonyms":["COMPOUND 99638","Cefaclor","Cefaclor hydrate"],"crossReferences":{"DailyMed":["cefaclor"],"PubChem":["144204431","170464885","29215008","855765"],"drugbank":["DB00833"],"chEBI":["3478"]},"childChemblIds":["CHEMBL1201018"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL720","canonicalSmiles":"OCc1ccccc1","inchiKey":"WVDDGKGOMKODPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYL ALCOHOL","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ulesfia"],"synonyms":["Benzyl Alcohol","Benzyl alcohol","E-1519","E1519","FEMA NO. 2137","INS NO.1519","INS-1519","NSC-8044","Phenylcarbinol"],"crossReferences":{"DailyMed":["benzyl%20alcohol"],"PubChem":["124891475","144204723","144209645","144210364","17390015"],"Wikipedia":["Benzyl_alcohol"],"drugbank":["DB06770"],"chEBI":["17987"]},"count":3,"approvedIndications":["EFO_0009560","MONDO_0003472","EFO_0001067"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 3 approved indications."}
{"id":"CHEMBL811","canonicalSmiles":"CN(C)CCC(c1ccc(Br)cc1)c1ccccn1","inchiKey":"ZDIGNSYAACHWNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMPHENIRAMINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BPN","Bromfed","Bromfenex","Brompheniramine","Dimetane","Dimetapp","Lodrane"],"crossReferences":{"DailyMed":["brompheniramine%20maleate"],"PubChem":["90341200"],"Wikipedia":["Brompheniramine"],"drugbank":["DB00835"],"chEBI":["3183"]},"childChemblIds":["CHEMBL1200961"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0008521","MP_0001845","HP_0012735","EFO_0007214","EFO_0003785"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for allergy."}
{"id":"CHEMBL859","canonicalSmiles":"O=c1[nH]c(=O)c2c[nH]nc2[nH]1","inchiKey":"HXNFUBHNUDHIGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPURINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-76239","Oxipurinol","Oxypurinol"],"crossReferences":{"PubChem":["144211537","57264357"],"Wikipedia":["Oxypurinol"],"drugbank":["DB05262"],"chEBI":["28315"]},"count":2,"linkedTargets":{"rows":["ENSG00000158125"],"count":1},"linkedDiseases":{"rows":["Orphanet_232","EFO_0000373"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL86304","canonicalSmiles":"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1","inchiKey":"YHXISWVBGDMDLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOCLOBEMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Manerix"],"synonyms":["GNF-PF-695","Moclobemide","RO 11-1163/000","RO-111163000"],"crossReferences":{"PubChem":["104171398","144204522","144207163","170465663","50086440","50105006","50105007","846440","90340853"],"Wikipedia":["Moclobemide"],"drugbank":["DB01171"],"chEBI":["83531"]},"count":6,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000189221"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","MONDO_0002050","HP_0000726","EFO_0003761","EFO_0003768","EFO_0005230","EFO_0000692"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for unipolar depression and has 5 investigational indications."}
{"id":"CHEMBL937","canonicalSmiles":"CCN(CC)C(=O)N1CCN(C)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"PGNKBEARDDELNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLCARBAMAZINE CITRATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL684","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Banocide","Decacide","Difil","Dirocide","Filarabits","Hetrazan","Nemacide"],"synonyms":["Diethylcarbamazine Citrate","Diethylcarbamazine citrate"],"crossReferences":{"PubChem":["11112950","11532955","124882739","144204299","170465631","26747989","56422104"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950."}
